Inferring amyloid pathologies among patients with mild cognitive impairment using phase‒amplitude coupling of electroencephalography: A case‒control study

Yuki Miyazaki, Masahiro Hata, Shun Takahashi, Ryohei Fukuma, Daiki Taomoto, Yuto Satake, Takashi Suehiro, Hideki Kanemoto, Kenji Yoshiyama, Keiko Matsunaga, Kayako Isohashi, Haruhiko Kishima, Manabu Ikeda, Takufumi YanagisawaInternational Psychogeriatrics 2025 · DOI

Abstract

Theta-high gamma PAC in resting-state EEG can distinguish amyloid PET-positive patients with MCI from PET-negative patients, thereby providing a feasible, noninvasive biomarker for AD pathology. Integrating PAC analysis into routine EEG could improve the early identification of individuals who qualify for DMTs, thereby facilitating timely intervention.
BibTeX
@inproceedings{miyazaki2025inferring,
  author = {Yuki Miyazaki and Masahiro Hata and Shun Takahashi and Ryohei Fukuma and Daiki Taomoto and Yuto Satake and Takashi Suehiro and Hideki Kanemoto and Kenji Yoshiyama and Keiko Matsunaga and Kayako Isohashi and Haruhiko Kishima and Manabu Ikeda and Takufumi Yanagisawa},
  title = {{Inferring amyloid pathologies among patients with mild cognitive impairment using phase‒amplitude coupling of electroencephalography: A case‒control study}},
  booktitle = {International Psychogeriatrics},
  year = {2025},
  doi = {10.1016/j.inpsyc.2025.100132},
}

Loading related content...

Figure